{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:23:13Z","timestamp":1786980193879,"version":"build-2736575974"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T00:00:00Z","timestamp":1676937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T00:00:00Z","timestamp":1676937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-023-04833-4","type":"journal-article","created":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T15:13:12Z","timestamp":1676992392000},"page":"1949-1963","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Safety, metabolic and psychological outcomes of Medtronic MiniMed 670G in children, adolescents and young adults: a systematic review"],"prefix":"10.1007","volume":"182","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3385-4128","authenticated-orcid":false,"given":"Chiara","family":"Mameli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia Marie","family":"Smylie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Galati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0062-6594","authenticated-orcid":false,"given":"Biagio","family":"Rapone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7067-1657","authenticated-orcid":false,"given":"Roque","family":"Cardona-Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2795-9874","authenticated-orcid":false,"given":"Gianvincenzo","family":"Zuccotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1528-0012","authenticated-orcid":false,"given":"Maurizio","family":"Delvecchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,21]]},"reference":[{"issue":"14","key":"4833_CR1","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1056\/NEJM199309303291401","volume":"329","author":"DM Nathan","year":"1993","unstructured":"Diabetes Control and Complications Trial Research Group, Nathan DM, Genuth S, Lachin J, Cleary P, Crofford O, Davis M, Rand L, Siebert C (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Eng J Med 329(14):977\u2013986. https:\/\/doi.org\/10.1056\/NEJM199309303291401","journal-title":"N Eng J Med"},{"issue":"2","key":"4833_CR2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.4155\/tde-2017-0099","volume":"9","author":"JY Stone","year":"2018","unstructured":"Stone JY, Haviland N, Bailey TS (2018) Review of a commercially available hybrid closed-loop insulin-delivery system in the treatment of Type 1 diabetes. Ther Deliv 9(2):77\u201387. https:\/\/doi.org\/10.4155\/tde-2017-0099","journal-title":"Ther Deliv"},{"issue":"5","key":"4833_CR3","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1177\/193229681200600517","volume":"6","author":"JL Ruiz","year":"2012","unstructured":"Ruiz JL, Sherr JL, Cengiz E, Carria L, Roy A, Voskanyan G, Tamborlane WV, Weinzimer SA (2012) Effect of insulin feedback on closed-loop glucose control: a crossover study. J Diabetes Sci Technol 6(5):1123\u20131130. https:\/\/doi.org\/10.1177\/193229681200600517","journal-title":"J Diabetes Sci Technol"},{"issue":"3","key":"4833_CR4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1089\/dia.2016.0421","volume":"19","author":"SK Garg","year":"2017","unstructured":"Garg SK, Weinzimer SA, Tamborlane WV, Buckingham BA, Bode BW, Bailey TS, Brazg RL, Ilany J, Slover RH, Anderson SM, Bergenstal RM, Grosman B, Roy A, Cordero TL, Shin J, Lee SW, Kaufman FR (2017) Glucose outcomes with the in-home use of a hybrid closed-loop insulin delivery system in adolescents and adults with type 1 diabetes. Diabetes Technol Ther 19(3):155\u2013163. https:\/\/doi.org\/10.1089\/dia.2016.0421","journal-title":"Diabetes Technol Ther"},{"issue":"4","key":"4833_CR5","doi-asserted-by":"publisher","first-page":"789","DOI":"10.2337\/dc17-1682","volume":"41","author":"LH Messer","year":"2018","unstructured":"Messer LH, Forlenza GP, Sherr JL, Wadwa RP, Buckingham BA, Weinzimer SA, Maahs DM, Slover RH (2018) Optimizing hybrid closed-loop therapy in adolescents and emerging adults using the MiniMed 670G system. Diabetes Care 41(4):789\u2013796. https:\/\/doi.org\/10.2337\/dc17-1682","journal-title":"Diabetes Care"},{"issue":"4","key":"4833_CR6","doi-asserted-by":"publisher","first-page":"W65","DOI":"10.7326\/0003-4819-151-4-200908180-00136","volume":"151","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, G\u00f8tzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 151(4):W65-94. https:\/\/doi.org\/10.7326\/0003-4819-151-4-200908180-00136","journal-title":"Ann Intern Med"},{"issue":"12","key":"4833_CR7","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1001\/jamapediatrics.2021.3965","volume":"175","author":"Abraham MA, Martin de Bock, Grant J Smith, Julie Dart, Janice M Fairchild, Bruce R King, Geoffrey R Ambler, Fergus J Cameron, Sybil A McAuley, Anthony C Keech, Alicia Jenkins, Elizabeth A Davis, David N O'Neal, Timothy W Jones, Australian Juvenile Diabetes Research Fund Closed-Loop Research group","year":"2021","unstructured":"Abraham MB, de Bock M, Smith GJ, Dart J, Fairchild JM, King BR, Ambler GR, Cameron FJ, McAuley SA, Keech AC, Jenkins A, Davis EA, O\u2019Neal DN, Jones TW, Australian Juvenile Diabetes Research Fund Closed-Loop Research group (2021) Effect of a hybrid closed-loop system on glycemic and psychosocial outcomes in children and adolescents with type 1 diabetes: a randomized clinical trial. JAMA Pediatr 175(12):1227\u20131235. https:\/\/doi.org\/10.1001\/jamapediatrics.2021.3965","journal-title":"JAMA Pediatr"},{"issue":"10","key":"4833_CR8","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1089\/dia.2018.0174","volume":"20","author":"RN Adams","year":"2018","unstructured":"Adams RN, Tanenbaum ML, Hanes SJ, Ambrosino JM, Ly TT, Maahs DM, Naranjo D, Walders-Abramson N, Weinzimer SA, Buckingham BA, Hood KK (2018) Psychosocial and human factors during a trial of a hybrid closed loop system for type 1 diabetes management. Diabetes Technol Ther 20(10):648\u2013653. https:\/\/doi.org\/10.1089\/dia.2018.0174","journal-title":"Diabetes Technol Ther"},{"issue":"12","key":"4833_CR9","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1089\/dia.2019.0400","volume":"22","author":"I Beato-V\u00edbora Pilar","year":"2020","unstructured":"Beato-V\u00edbora Pilar I, Gallego-Gamero F, L\u00e1zaro-Mart\u00edn L, Romero-P\u00e9rez MdM, Arroyo-D\u00edez FJ (2020) Prospective analysis of the impact of commercialized hybrid closed-loop system on glycemic control, glycemic variability, and patient-related outcomes in children and adults: a focus on superiority over predictive low-glucose suspend technology. Diabetes Technol Ther 22(12):912\u2013919. https:\/\/doi.org\/10.1089\/dia.2019.0400","journal-title":"Diabetes Technol Ther"},{"issue":"13","key":"4833_CR10","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1001\/jama.2016.11708","volume":"316","author":"RM Bergenstal","year":"2016","unstructured":"Bergenstal RM, Garg S, Weinzimer SA, Buckingham BA, Bode BW, Tamborlane WV, Kaufman FR (2016) Safety of a hybrid closed-loop insulin delivery system in patients with type 1 diabetes. JAMA 316(13):1407\u20131408. https:\/\/doi.org\/10.1001\/jama.2016.11708","journal-title":"JAMA"},{"issue":"10270","key":"4833_CR11","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/S0140-6736(20)32514-9","volume":"397","author":"Bergenstal RM, Nimri R, Beck RW, Criego A, Laffel L, Schatz D, Battelino T, Danne T, Weinzimer SA, Sibayan J, Johnson ML, Bailey RJ, Calhoun P, Carlson A, Isganaitis E, Bello R, Albanese-O\u2019Neill A, Dovc K, Biester T, Weyman K, Hood K, Phillip M, for the FLAIR Study Group*","year":"2021","unstructured":"Bergenstal RM, Nimri R, Beck RW, Criego A, Laffel L, Schatz D, Battelino T, Danne T, Weinzimer SA, Sibayan J, Johnson ML, Bailey RJ, Calhoun P, Carlson A, Isganaitis E, Bello R, Albanese-O\u2019Neill A, Dovc K, Biester T, Weyman K, Hood K, Phillip M, for the FLAIR Study Group (2021) A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial. Lancet 397(10270):208\u2013219","journal-title":"Lancet"},{"issue":"2","key":"4833_CR12","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/pedi.12962","volume":"21","author":"C Berget","year":"2020","unstructured":"Berget C, Messer LH, Vigers T, Frohnert BI, Pyle L, Wadwa RP, Driscoll KA, Forlenza GP (2020) Six months of hybrid closed loop in the real-world: an evaluation of children and young adults using the 670G system. Pediatr Diabetes 21(2):310\u2013318. https:\/\/doi.org\/10.1111\/pedi.12962","journal-title":"Pediatr Diabetes"},{"issue":"9","key":"4833_CR13","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1111\/dom.14441","volume":"23","author":"C Berget","year":"2021","unstructured":"Berget C, Akturk HK, Messer LH, Vigers T, Pyle L, Snell-Bergeon J, Driscoll KA, Forlenza GP (2021) Real-world performance of hybrid closed loop in youth, young adults, adults and older adults with type 1 diabetes: Identifying a clinical target for hybrid closed-loop use. Diabetes Obes Metab 23(9):2048\u20132057. https:\/\/doi.org\/10.1111\/dom.14441","journal-title":"Diabetes Obes Metab"},{"issue":"11","key":"4833_CR14","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1089\/dia.2020.0057","volume":"22","author":"EC Cobry","year":"2020","unstructured":"Cobry EC, Hamburger E, Jaser SS (2020) Impact of the hybrid closed-loop system on sleep and quality of life in youth with type 1 diabetes and their parents. Diabetes Technol Ther 22(11):794\u2013800. https:\/\/doi.org\/10.1089\/dia.2020.0057","journal-title":"Diabetes Technol Ther"},{"issue":"12","key":"4833_CR15","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1089\/dia.2017.0208","volume":"19","author":"TL Cordero","year":"2017","unstructured":"Cordero TL, Garg SK, Brazg R, Bailey TS, Shin J, Lee SW, Kaufman FR (2017) The effect of prior continuous glucose monitoring use on glycemic outcomes in the pivotal trial of the MiniMed\u2122 670G Hybrid closed-loop system. Diabetes Technol Ther 19(12):749\u2013752. https:\/\/doi.org\/10.1089\/dia.2017.0208","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"4833_CR16","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1177\/1932296816668876","volume":"11","author":"M de Bock","year":"2017","unstructured":"de Bock M, Dart J, Roy A, Davey R, Soon W, Berthold C, Retterath A, Grosman B, Kurtz N, Davis E, Jones T (2017) Exploration of the performance of a hybrid closed loop insulin delivery algorithm that includes insulin delivery limits designed to protect against hypoglycemia. J Diabetes Sci Technol 11(1):68\u201373. https:\/\/doi.org\/10.1177\/1932296816668876","journal-title":"J Diabetes Sci Technol"},{"key":"4833_CR17","doi-asserted-by":"publisher","unstructured":"de Bock M, Dart J, Hancock M, Smith G, Davis EA, Jones TW (2018) Performance of Medtronic hybrid closed-loop iterations. results from a randomized trial in adolescents with type 1 diabetes. Diabetes Technol Ther 20(10):693\u2013697. https:\/\/doi.org\/10.1089\/dia.2018.0161","DOI":"10.1089\/dia.2018.0161"},{"key":"4833_CR18","doi-asserted-by":"publisher","unstructured":"Dominguez-Riscart J, Buero-Fernandez N, Garcia-Zarzuela A, Marmolejo-Franco FA, Perez-Guerrero AC, Lechuga-Sancho AM (2021) Hybrid closed-loop system achieves optimal perioperative glycemia in a boy with type 1 diabetes: a case report. Front Pediatr 9:625390. https:\/\/doi.org\/10.3389\/fped.2021.625390","DOI":"10.3389\/fped.2021.625390"},{"issue":"4","key":"4833_CR19","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1111\/dom.13912","volume":"22","author":"SH Duffus","year":"2020","unstructured":"Duffus SH, Ta\u2019ani ZA, Slaughter JC, Niswender KD, Gregory JM (2020) Increased proportion of time in hybrid closed-loop \u201cAuto Mode\u201d is associated with improved glycaemic control for adolescent and young patients with adult type 1 diabetes using the MiniMed 670G insulin pump. Diabetes Obes Metab 22(4):688\u2013693. https:\/\/doi.org\/10.1111\/dom.13912","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"4833_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1089\/dia.2018.0264","volume":"21","author":"GP Forlenza","year":"2019","unstructured":"Forlenza GP, Pinhas-Hamiel O, Liljenquist DR, Shulman DI, Bailey TS, Bode BW, Wood MA, Buckingham BA, Kaiserman KB, Shin J, Huang S, Lee SW, Kaufman FR (2019) Safety evaluation of the MiniMed 670G system in children 7\u201313 years of age with type 1 diabetes. Diabetes Technol Ther 21(1):11\u201319. https:\/\/doi.org\/10.1089\/dia.2018.0264","journal-title":"Diabetes Technol Ther"},{"issue":"3","key":"4833_CR21","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/pedi.13312","volume":"23","author":"GP Forlenza","year":"2022","unstructured":"Forlenza GP, Ekhlaspour L, DiMeglio LA, Fox LA, Rodriguez H, Shulman DI, Kaiserman KB, Liljenquist DR, Shin J, Lee SW, Buckingham BA (2022) Glycemic outcomes of children 2\u20136 years of age with type 1 diabetes during the pediatric MiniMed\u2122 670G system trial. Pediatr Diabetes 23(3):324\u2013329. https:\/\/doi.org\/10.1111\/pedi.13312","journal-title":"Pediatr Diabetes"},{"issue":"6","key":"4833_CR22","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.eprac.2020.11.017","volume":"27","author":"LM Nally","year":"2021","unstructured":"Nally LM, Wagner J, Sherr J, Tichy E, Weyman K, Ginley MK, Zajac K, Desousa M, Shabanova V, Petry NM, Tamborlane WV, Van Name M (2021) A Pilot study of youth with type 1 diabetes initiating use of a hybrid closed-loop system while receiving a behavioral economics intervention. Endocr Pract 27(6):545\u2013551. https:\/\/doi.org\/10.1016\/j.eprac.2020.11.017","journal-title":"Endocr Pract"},{"key":"4833_CR23","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1007\/s13300-018-0473-6","volume":"9","author":"AK Petrovski","year":"2018","unstructured":"Petrovski G, Al Khalaf F, Hussain K, Campbell J (2018) Optimizing a hybrid closed loop system in type 1 diabetes: a case report. Diabetes Ther 9:2173\u20132177. https:\/\/doi.org\/10.1007\/s13300-018-0473-6","journal-title":"Diabetes Ther"},{"issue":"1","key":"4833_CR24","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s00592-019-01414-6","volume":"57","author":"G Petrovski","year":"2020","unstructured":"Petrovski G, Al Khalaf F, Campbell J, Hussain K, Fisher H, Umer F (2020) Glucose control during Ramadan fasting in a teenager with type 1 diabetes on MiniMed 670G hybrid closed-loop system. Acta Diabetol 57(1):105\u2013107. https:\/\/doi.org\/10.1007\/s00592-019-01414-6","journal-title":"Acta Diabetol"},{"issue":"6","key":"4833_CR25","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s00592-019-01472-w","volume":"57","author":"G Petrovski","year":"2020","unstructured":"Petrovski G, Khalaf FA, Campbel J, Fisher H, Umer F, Hussain K (2020) 10-Day structured initiation protocol from multiple daily injection to hybrid closed-loop system in children and adolescents with type 1 diabetes. Acta Diabetol 57(6):681\u2013687. https:\/\/doi.org\/10.1007\/s00592-019-01472-w","journal-title":"Acta Diabetol"},{"issue":"2","key":"4833_CR26","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s00592-020-01607-4","volume":"58","author":"G Petrovski","year":"2021","unstructured":"Petrovski G, Al Khalaf F, Campbell J, Umer F, Almajaly D, Hamdan M, Hussain K (2021) One-year experience of hybrid closed-loop system in children and adolescents with type 1 diabetes previously treated with multiple daily injections: drivers to successful outcomes. Acta Diabetol 58(2):207\u2013213. https:\/\/doi.org\/10.1007\/s00592-020-01607-4","journal-title":"Acta Diabetol"},{"issue":"6","key":"4833_CR27","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1177\/1932296820950753","volume":"15","author":"G Petrovski","year":"2021","unstructured":"Petrovski G, Campbell J, Almajali D, Al Khalaf F, Hussain K (2021) Successful initiation of hybrid closed-loop system using virtual pump training program in a teenager with type 1 diabetes previously treated with multiple daily injections. J Diabetes Sci Technol 15(6):1394\u20131398. https:\/\/doi.org\/10.1177\/1932296820950753","journal-title":"J Diabetes Sci Technol"},{"key":"4833_CR28","doi-asserted-by":"publisher","unstructured":"Roberts A, Fried L, Dart J, de Bock M, Fairchild J, King B, Ambler GR, Cameron F, McAuley SA, Keech AC, Jenkins A, O Neal DN, Davis EA, Jones TW, Abraham MB, Australian JDRF Closed Loop Research Group (2022) Hybrid closed-loop therapy with a first-generation system increases confidence and independence in diabetes management in youth with type 1 diabetes. Diabet Med 39(9):e14907. https:\/\/doi.org\/10.1111\/dme.14907","DOI":"10.1111\/dme.14907"},{"issue":"8","key":"4833_CR29","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1089\/dia.2019.0123","volume":"21","author":"P Salehi","year":"2019","unstructured":"Salehi P, Roberts AJ, Kim GJ (2019) Efficacy and safety of real-life usage of MiniMed 670G automode in children with type 1 diabetes less than 7 years old. Diabetes Technol Ther 21(8):448\u2013451. https:\/\/doi.org\/10.1089\/dia.2019.0123","journal-title":"Diabetes Technol Ther"},{"issue":"10","key":"4833_CR30","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1089\/dia.2018.0202","volume":"20","author":"PM Stone","year":"2018","unstructured":"Stone PM, Agrawal P, Chen X, Liu M, Shin J, Cordero TL, Kaufman FR (2018) Retrospective analysis of 3-month real-world glucose data after the MiniMed 670G system commercial launch. Diabetes Technol Ther 20(10):689\u2013692. https:\/\/doi.org\/10.1089\/dia.2018.0202","journal-title":"Diabetes Technol Ther"},{"issue":"6","key":"4833_CR31","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1111\/pedi.13235","volume":"22","author":"T Varimo","year":"2021","unstructured":"Varimo T, Pulkkinen MA, Hakonen E, Hero M, Miettinen PJ, Tuomaala AK (2021) First year on commercial hybrid closed-loop system-experience on 111 children and adolescents with type 1 diabetes. Pediatr Diabetes 22(6):909\u2013915. https:\/\/doi.org\/10.1111\/pedi.13235","journal-title":"Pediatr Diabetes"},{"issue":"6","key":"4833_CR32","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1089\/dia.2020.0169","volume":"22","author":"G Tornese","year":"2020","unstructured":"Tornese G, Ceconi V, Monasta L, Carletti C, Faleschini E, Barbi E (2020) Glycemic control in type 1 diabetes mellitus during covid-19 quarantine and the role of in-home physical activity. Diabetes Technol Ther 22(6):462\u2013467. https:\/\/doi.org\/10.1089\/dia.2020.0169","journal-title":"Diabetes Technol Ther"},{"issue":"7","key":"4833_CR33","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1111\/dom.14706","volume":"24","author":"T von dem Berge","year":"2022","unstructured":"von dem Berge T, Remus K, Biester S, Reschke F, Klusmeier B, Adolph K, Holtdirk A, Thomas A, Kordonouri O, Danne T, Biester T (2022) In-home use of a hybrid closed loop achieves time-in-range targets in preschoolers and school children: Results from a randomized, controlled, crossover trial. Diabetes Obes Metab 24(7):1319\u20131327. https:\/\/doi.org\/10.1111\/dom.14706","journal-title":"Diabetes Obes Metab"},{"issue":"11","key":"4833_CR34","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1089\/dia.2018.0209","volume":"20","author":"MA Wood","year":"2018","unstructured":"Wood MA, Shulman DI, Forlenza GP, Bode BW, Pinhas-Hamiel O, Buckingham BA, Kaiserman KB, Liljenquist DR, Bailey TS, Shin J, Huang S, Chen X, Cordero TL, Lee SW, Kaufman FR (2018) In-clinic evaluation of the MiniMed 670G system \u201csuspend before low\u201d feature in children with type 1 diabetes. Diabetes Technol Ther 20(11):731\u2013737. https:\/\/doi.org\/10.1089\/dia.2018.0209","journal-title":"Diabetes Technol Ther"},{"issue":"8","key":"4833_CR35","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.2337\/dci19-0028","volume":"42","author":"T Battelino","year":"2019","unstructured":"Battelino T, Danne T, Bergenstal RM, Amiel SA, Beck R, Biester T, Bosi E, Buckingham BA, Cefalu WT, Close KL, Cobelli C, Dassau E, DeVries JH, Donaghue KC, Dovc K, Doyle FJ 3rd, Garg S, Grunberger G, Heller S, Heinemann L, Hirsch IB, Hovorka R, Jia W, Kordonouri O, Kovatchev B, Kowalski A, Laffel L, Levine B, Mayorov A, Mathieu C, Murphy HR, Nimri R, N\u00f8rgaard K, Parkin CG, Renard E, Rodbard D, Saboo B, Schatz D, Stoner K, Urakami T, Weinzimer SA, Phillip M (2019) Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care 42(8):1593\u20131603. https:\/\/doi.org\/10.2337\/dci19-0028","journal-title":"Diabetes Care"},{"key":"4833_CR36","doi-asserted-by":"publisher","unstructured":"Bergenstal RM, Nimri R, Beck RW, Criego A, Laffel L, Schatz D, Battelino T, Danne T, Weinzimer SA, Sibayan J, Johnson ML, Bailey RJ, Calhoun P, Carlson A, Isganaitis E, Bello R, Albanese-O'Neill A, Dovc K, Biester T, Weyman K, Hood K, Phillip M, FLAIR Study Group (2021) A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial. Lancet 16;397(10270):208\u2013219. https:\/\/doi.org\/10.1016\/S0140-6736(20)32514-9","DOI":"10.1016\/S0140-6736(20)32514-9"},{"issue":"4","key":"4833_CR37","doi-asserted-by":"publisher","first-page":"969","DOI":"10.2337\/dc20-2250","volume":"44","author":"OJ Collyns","year":"2021","unstructured":"Collyns OJ, Meier RA, Betts ZL, Chan DSH, Frampton C, Frewen CM, Hewapathirana NM, Jones SD, Roy A, Grosman B, Kurtz N, Shin J, Vigersky RA, Wheeler BJ, de Bock MI (2021) Improved glycemic outcomes with medtronic minimed advanced hybrid closed-loop delivery: results from a randomized crossover trial comparing automated insulin delivery with predictive low glucose suspend in people with type 1 diabetes. Diabetes Care 44(4):969\u2013975. https:\/\/doi.org\/10.2337\/dc20-2250","journal-title":"Diabetes Care"},{"issue":"2","key":"4833_CR38","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1089\/dia.2021.0203","volume":"24","author":"JD Silva","year":"2022","unstructured":"Silva JD, Lepore G, Battelino T, Arrieta A, Casta\u00f1eda J, Grossman B, Shin J, Cohen O (2022) Real-world performance of the MiniMed\u2122 780G System: first report of outcomes from 4120 users. Diabetes Technol Ther 24(2):113\u2013119. https:\/\/doi.org\/10.1089\/dia.2021.0203","journal-title":"Diabetes Technol Ther"},{"issue":"7","key":"4833_CR39","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1111\/dom.14714","volume":"24","author":"A Arrieta","year":"2022","unstructured":"Arrieta A, Battelino T, Scaramuzza AE, Da Silva J, Casta\u00f1eda J, Cordero TL, Shin J, Cohen O (2022) Comparison of MiniMed 780G system performance in users aged younger and older than 15 years: evidence from 12 870 real-world users. Diabetes Obes Metab 24(7):1370\u20131379. https:\/\/doi.org\/10.1111\/dom.14714","journal-title":"Diabetes Obes Metab"},{"issue":"18","key":"4833_CR40","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1056\/NEJMoa1907863","volume":"381","author":"Brown SA, Kovatchev BP, Raghinaru D, Lum JW, Buckingham BA, Kudva YC, Laffel LM, Levy CJ, Pinsker JE, Wadwa RP, Dassau E, Doyle FJ 3rd, Anderson SM, Church MM, Dadlani V, Ekhlaspour L, Forlenza GP, Isganaitis E, Lam DW, Kollman C, Beck RW; iDCL Trial Research Group","year":"2019","unstructured":"Brown SA, Kovatchev BP, Raghinaru D, Lum JW, Buckingham BA, Kudva YC, Laffel LM, Levy CJ, Pinsker JE, Wadwa RP, Dassau E, Doyle FJ 3rd, Anderson SM, Church MM, Dadlani V, Ekhlaspour L, Forlenza GP, Isganaitis E, Lam DW, Kollman C, Beck RW, iDCL Trial Research Group (2019) Six-month randomized, multicenter trial of closed-loop control in type 1 diabetes. N Engl J Med 381(18):1707\u20131717. https:\/\/doi.org\/10.1056\/NEJMoa1907863","journal-title":"N Engl J Med"},{"issue":"9","key":"4833_CR41","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1056\/NEJMoa2004736","volume":"383","author":"Breton MD, Kanapka LG, Beck RW, Ekhlaspour L, Forlenza GP, Cengiz E, Schoelwer M, Ruedy KJ, Jost E, Carria L, Emory E, Hsu LJ, Oliveri M, Kollman CC, Dokken BB, Weinzimer SA, DeBoer MD, Buckingham BA, Cher\u00f1avvsky D, Wadwa RP; iDCL Trial Research Group","year":"2020","unstructured":"Breton MD, Kanapka LG, Beck RW, Ekhlaspour L, Forlenza GP, Cengiz E, Schoelwer M, Ruedy KJ, Jost E, Carria L, Emory E, Hsu LJ, Oliveri M, Kollman CC, Dokken BB, Weinzimer SA, DeBoer MD, Buckingham BA, Cher\u00f1avvsky D, Wadwa RP; iDCL Trial Research Group (2020) A randomized trial of closed-loop control in children with type 1 diabetes. N Engl J Med 383(9):836\u2013845. https:\/\/doi.org\/10.1056\/NEJMoa2004736","journal-title":"N Engl J Med"},{"issue":"2","key":"4833_CR42","doi-asserted-by":"publisher","first-page":"473","DOI":"10.2337\/dc20-1729","volume":"44","author":"Kanapka LG, Wadwa RP, Breton MD, Ruedy KJ, Ekhlaspour L, Forlenza GP, Cengiz E, Schoelwer MJ, Jost E, Carria L, Emory E, Hsu LJ, Weinzimer SA, DeBoer MD, Buckingham BA, Oliveri M, Kollman C, Dokken BB, Cher\u00f1avvsky D, Beck RW; iDCL Trial Research Group","year":"2021","unstructured":"Kanapka LG, Wadwa RP, Breton MD, Ruedy KJ, Ekhlaspour L, Forlenza GP, Cengiz E, Schoelwer MJ, Jost E, Carria L, Emory E, Hsu LJ, Weinzimer SA, DeBoer MD, Buckingham BA, Oliveri M, Kollman C, Dokken BB, Cher\u00f1avvsky D, Beck RW; iDCL Trial Research Group (2021) Extended use of the control-IQ closed-loop control system in children with type 1 diabetes. Diabetes Care 44(2):473\u2013478. https:\/\/doi.org\/10.2337\/dc20-1729","journal-title":"Diabetes Care"},{"issue":"9","key":"4833_CR43","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1089\/dia.2021.0097","volume":"23","author":"MD Breton","year":"2021","unstructured":"Breton MD, Kovatchev BP (2021) One year real-world use of the control-IQ advanced hybrid closed-loop technology. Diabetes Technol Ther 23(9):601\u2013608. https:\/\/doi.org\/10.1089\/dia.2021.0097","journal-title":"Diabetes Technol Ther"},{"issue":"3","key":"4833_CR44","doi-asserted-by":"publisher","first-page":"e158","DOI":"10.1016\/S2589-7500(21)00271-5","volume":"4","author":"D Kariyawasam","year":"2022","unstructured":"Kariyawasam D, Morin C, Casteels K, Le Tallec C, Sfez A, Godot C, Huneker E, Garrec N, Benhamou PY, Polak M, Charpentier G, Franc S, Beltrand J (2022) Hybrid closed-loop insulin delivery versus sensor-augmented pump therapy in children aged 6\u201312 years: a randomised, controlled, cross-over, non-inferiority trial. Lancet Digit Health 4(3):e158\u2013e168. https:\/\/doi.org\/10.1016\/S2589-7500(21)00271-5","journal-title":"Lancet Digit Health"},{"issue":"4","key":"4833_CR45","doi-asserted-by":"publisher","first-page":"e245","DOI":"10.1016\/S2589-7500(22)00020-6","volume":"4","author":"Ware J, Boughton CK, Allen JM, Wilinska ME, Tauschmann M, Denvir L, Thankamony A, Campbell FM, Wadwa RP, Buckingham BA, Davis N, DiMeglio LA, Mauras N, Besser REJ, Ghatak A, Weinzimer SA, Hood KK, Fox DS, Kanapka L, Kollman C, Sibayan J, Beck RW, Hovorka R; DAN05 Consortium","year":"2022","unstructured":"Ware J, Boughton CK, Allen JM, Wilinska ME, Tauschmann M, Denvir L, Thankamony A, Campbell FM, Wadwa RP, Buckingham BA, Davis N, DiMeglio LA, Mauras N, Besser REJ, Ghatak A, Weinzimer SA, Hood KK, Fox DS, Kanapka L, Kollman C, Sibayan J, Beck RW, Hovorka R; DAN05 Consortium (2022) Cambridge hybrid closed-loop algorithm in children and adolescents with type 1 diabetes: a multicentre 6-month randomised controlled trial. Lancet Digit Health 4(4):e245\u2013e255. https:\/\/doi.org\/10.1016\/S2589-7500(22)00020-6","journal-title":"Lancet Digit Health"},{"issue":"10155","key":"4833_CR46","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/S0140-6736(18)31947-0","volume":"392","author":"Tauschmann M, Thabit H, Bally L, Allen JM, Hartnell S, Wilinska ME, Ruan Y, Sibayan J, Kollman C, Cheng P, Beck RW, Acerini CL, Evans ML, Dunger DB, Elleri D, Campbell F, Bergenstal RM, Criego A, Shah VN, Leelarathna L, Hovorka R; APCam11 Consortium","year":"2018","unstructured":"Tauschmann M, Thabit H, Bally L, Allen JM, Hartnell S, Wilinska ME, Ruan Y, Sibayan J, Kollman C, Cheng P, Beck RW, Acerini CL, Evans ML, Dunger DB, Elleri D, Campbell F, Bergenstal RM, Criego A, Shah VN, Leelarathna L, Hovorka R; APCam11 Consortium (2018) Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial. Lancet 392(10155):1321\u20131329. https:\/\/doi.org\/10.1016\/S0140-6736(18)31947-0. Erratum. In: Lancet 2018;392(10155):1310","journal-title":"Lancet"},{"issue":"3","key":"4833_CR47","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1056\/NEJMoa2111673","volume":"386","author":"Ware J, Allen JM, Boughton CK, Wilinska ME, Hartnell S, Thankamony A, de Beaufort C, Schierloh U, Fr\u00f6hlich-Reiterer E, Mader JK, Kapellen TM, Rami-Merhar B, Tauschmann M, Nagl K, Hofer SE, Campbell FM, Yong J, Hood KK, Lawton J, Roze S, Sibayan J, Bocchino LE, Kollman C, Hovorka R; KidsAP Consortium","year":"2022","unstructured":"Ware J, Allen JM, Boughton CK, Wilinska ME, Hartnell S, Thankamony A, de Beaufort C, Schierloh U, Fr\u00f6hlich-Reiterer E, Mader JK, Kapellen TM, Rami-Merhar B, Tauschmann M, Nagl K, Hofer SE, Campbell FM, Yong J, Hood KK, Lawton J, Roze S, Sibayan J, Bocchino LE, Kollman C, Hovorka R; KidsAP Consortium (2022) Randomized trial of closed-loop control in very young children with type 1 diabetes. N Engl J Med 386(3):209\u2013219. https:\/\/doi.org\/10.1056\/NEJMoa2111673","journal-title":"N Engl J Med"},{"issue":"7","key":"4833_CR48","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.2337\/dc21-0172","volume":"44","author":"Brown SA, Forlenza GP, Bode BW, Pinsker JE, Levy CJ, Criego AB, Hansen DW, Hirsch IB, Carlson AL, Bergenstal RM, Sherr JL, Mehta SN, Laffel LM, Shah VN, Bhargava A, Weinstock RS, MacLeish SA, DeSalvo DJ, Jones TC, Aleppo G, Buckingham BA, Ly TT; Omnipod 5 Research Group","year":"2021","unstructured":"Brown SA, Forlenza GP, Bode BW, Pinsker JE, Levy CJ, Criego AB, Hansen DW, Hirsch IB, Carlson AL, Bergenstal RM, Sherr JL, Mehta SN, Laffel LM, Shah VN, Bhargava A, Weinstock RS, MacLeish SA, DeSalvo DJ, Jones TC, Aleppo G, Buckingham BA, Ly TT; Omnipod 5 Research Group (2021) Multicenter trial of a tubeless, on-body automated insulin delivery system with customizable glycemic targets in pediatric and adult participants with type 1 diabetes. Diabetes Care 44(7):1630\u20131640. https:\/\/doi.org\/10.2337\/dc21-0172","journal-title":"Diabetes Care"},{"issue":"2","key":"4833_CR49","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/pedi.12971","volume":"21","author":"LH Messer","year":"2020","unstructured":"Messer LH, Berget C, Vigers T, Pyle L, Geno C, Wadwa RP, Driscoll KA, Forlenza GP (2020) Real world hybrid closed-loop discontinuation: Predictors and perceptions of youth discontinuing the 670G system in the first 6 months. Pediatr Diabetes 21(2):319\u2013327. https:\/\/doi.org\/10.1111\/pedi.12971","journal-title":"Pediatr Diabetes"},{"issue":"12","key":"4833_CR50","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.2337\/dc19-0855","volume":"42","author":"RA Lal","year":"2019","unstructured":"Lal RA, Basina M, Maahs DM, Hood K, Buckingham B, Wilson DM (2019) One year clinical experience of the first commercial hybrid closed-loop system. Diabetes Care 42(12):2190\u20132196. https:\/\/doi.org\/10.2337\/dc19-0855","journal-title":"Diabetes Care"},{"issue":"1","key":"4833_CR51","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1080\/13696998.2021.193970","volume":"24","author":"S Roze","year":"2021","unstructured":"Roze S, Buompensiere MI, Ozdemir Z, de Portu S, Cohen O (2021) Cost-effectiveness of a novel hybrid closed-loop system compared with continuous subcutaneous insulin infusion in people with type 1 diabetes in the UK. J Med Econ 24(1):883\u2013890. https:\/\/doi.org\/10.1080\/13696998.2021.193970","journal-title":"J Med Econ"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-023-04833-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-023-04833-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-023-04833-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:04:02Z","timestamp":1744157042000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-023-04833-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,21]]},"references-count":51,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["4833"],"URL":"https:\/\/doi.org\/10.1007\/s00431-023-04833-4","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,21]]},"assertion":[{"value":"6 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}